Status:
COMPLETED
Tranexamic Acid : Nebulization vs IV Route for Hemoptysis
Lead Sponsor:
University of Health Sciences Lahore
Conditions:
Hemoptysis
NEBULIZATION
Eligibility:
All Genders
12-80 years
Phase:
PHASE2
PHASE3
Brief Summary
This study compares the effect of tranexamic acid on hemoptysis when given through the conventional IV route and Through nebulization.
Detailed Description
The investigators are conducting a randomized controlled trial for the comparison of routes through which tranexamic acid can be given to control hemoptysis. The study participants will be divided int...
Eligibility Criteria
Inclusion
- Patients with mild to moderate hemoptysis \< 600ml/ 24 hours of age 12 to 80 years and both genders.
- Patients with hemoptysis due to infective pathology.
- Patients with hemoptysis due to malignant pathology.
Exclusion
- Patients on antiplatelet therapy or aspirin
- Hemoptysis after penetrating lung injury e.g. firearm injury
- Patients with history of asthma
Key Trial Info
Start Date :
August 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2025
Estimated Enrollment :
172 Patients enrolled
Trial Details
Trial ID
NCT07212452
Start Date
August 1 2025
End Date
October 31 2025
Last Update
November 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Services Hospital Lahore
Lahore, Punjab Province, Pakistan, 54000